NM_000527.5:c.1A>T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PS3PS1PVS1_ModeratePM2PP4PS4_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.1A>T (p.Met1Leu) variant is classified as Pathogenic for Familial Hypercholesterolemia by applying evidence codes PS1, PS3, PM2, PVS1_Moderate, PP4 and PS4_Supporting as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (https://doi.org/10.1016/j.gim.2021.09.012).The supporting evidence is as follows:PS1 - One more missense variant that leads to the same amino acid change: (1)NM_000527.5(LDLR):c.1A>C (p.Met1Leu) (ClinVar ID 250966) - Pathogenic by these guidelines--- variant is classified as Pathogenic, so PS1 is Met.PS3 - Level 1 (and other levels) FS: Graça et al., 2021 (PMID 34572405) Heterologous cells (CHO), FACS, luciferase and microscopy assays: FACS: 10% cell surface LDLR, 3% binding and 8% uptake; luciferase : 1% luciferase construct activity; microscopy: 5-10% LDLR expression and 5-10% LDLR activity.--- functional study in heterologous cells results in expression, binding and uptake less than 70% of wild-type, so PS3 is met.PM2 - This variant was not identified in gnomAD (gnomAD v2.1.1), so PM2 is met.PVS1_moderate - Variant is in initiation codon, so PVS1_Moderate is Met.PS4_supporting - Variant meets PM2 and was identified in:- 1 index case with DLCN score above 6 from University of British Columbia, Canada;- 1 index case with Simon-Broome criteria of possible FH from Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies (APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière), France;- 1 index case with Simon-Broome criteria of possible FH (Inclusion: LDL-C level>95th percentile for age and gender and autosomal dominant inheritance pattern of hypercholesterolemia, and a family history of hypercholesterolemia and cardiovascular disease) from PMID:21382890 (van der Graaf et al., 2011), The Netherlands;- 1 index case with Simon-Broome criteria of at least possible FH from PMID:17094996 (Tosi et al., 2007), UK.--- 4 cases, so PS4_Supporting is MetPP4 - Variant meets PM2 and was identified in 4 unrelated index cases who fulfill clinical FH criteria from different labs (see PS4 for details), so PP4 is Met. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10584720/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 initiator_codon
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | MANE Select | c.1A>T | p.Met1? | initiator_codon | Exon 1 of 18 | NP_000518.1 | P01130-1 | |
| LDLR | NM_001195798.2 | c.1A>T | p.Met1? | initiator_codon | Exon 1 of 18 | NP_001182727.1 | P01130-5 | ||
| LDLR | NM_001195799.2 | c.1A>T | p.Met1? | initiator_codon | Exon 1 of 17 | NP_001182728.1 | P01130-4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | ENST00000558518.6 | TSL:1 MANE Select | c.1A>T | p.Met1? | initiator_codon | Exon 1 of 18 | ENSP00000454071.1 | P01130-1 | |
| LDLR | ENST00000558013.5 | TSL:1 | c.1A>T | p.Met1? | initiator_codon | Exon 1 of 18 | ENSP00000453346.1 | P01130-5 | |
| LDLR | ENST00000557933.5 | TSL:5 | c.1A>T | p.Met1? | initiator_codon | Exon 1 of 18 | ENSP00000453557.1 | H0YMD1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at